首页> 外国专利> QUINOLIN AND QUINAZOLINE COMPOUNDS, A PHARMACEUTICAL COMPOSITION BASED THEREON, A METHOD FOR PREPARING THEREOF (ALTERNATIVES), INTERMEDIATE COMPOUNDS (ALTERNATIVES), A METHOD FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA.

QUINOLIN AND QUINAZOLINE COMPOUNDS, A PHARMACEUTICAL COMPOSITION BASED THEREON, A METHOD FOR PREPARING THEREOF (ALTERNATIVES), INTERMEDIATE COMPOUNDS (ALTERNATIVES), A METHOD FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA.

机译:喹诺林和喹唑啉化合物,基于其的药物组合物,其制备方法(替代物),中间化合物(替代物),贝宁前列腺增生症的治疗方法。

摘要

Compounds of formula (I), wherein R' represents C1-4 alkoxy optionally substituted by one or more fluorine atoms; R2 represents H or C1-6 alkoxy optionally substituted by one or more fluorine atoms; R3 represents a 5- or 6-membered heterocyclic ring, the ring being optionally substituted; R4 represents a 4-, 5-, 6- or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring, the ring system as a whole being optionally substituted; X represents CH or N; and L is absent, or represents a cyclic group of formula (la), or represents a chain of formula (Ib), and pharmaceutically acceptable salts thereof; are useful in therapy, in particular in the treatment of benign prostatic hyperplasia.
机译:式(I)化合物,其中R′代表任选被一个或多个氟原子取代的C1-4烷氧基; R 2代表任选被一个或多个氟原子取代的H或C 1-6烷氧基; R3代表5或6元杂环,该环是任选取代的; R4代表4、5、6或7元杂环,该环任选地稠合至苯环或5或6元杂环,整个环系统任选地被取代; X代表CH或N; L不存在,或代表式(Ia)的环状基团,或代表式(Ib)的链,及其药学上可接受的盐;可用于治疗,特别是良性前列腺增生的治疗。

著录项

  • 公开/公告号UA62945C2

    专利类型

  • 公开/公告日1999-12-29

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号UA19990073901

  • 发明设计人

    申请日1998-01-06

  • 分类号C07D409/04;A61K31/47;A61K31/505;C07D405/04;C07D401/04;C07D471/04;C07D401/14;C07D413/04;7C07D221:00B;

  • 国家 UA

  • 入库时间 2022-08-22 01:54:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号